CHER Trial Children with Early ART) At median follow-up 32wk, 76% reduction in mortality P=0.0002; 75% reduction in disease progression; Between early arms and deferred arm Death Disease progression Violari et al, IAS June 2007; NEJM 359;21 Nov 20, 2008 Professor Di Gibb, 13 Dec 2011
{}